metabolic
CagriSema
Amylin + GLP-1 combination research stack
Cheapest offer
$13.32/mg
1 vendors tracked1 live pricesLast crawl: 2026-06-11 00:03 UTC
About
A combination of cagrilintide and semaglutide in late-stage clinical development for obesity. Research-compound version mirrors the clinical dose ratio.
Also known as: Cagrilintide + Semaglutide combination, GLP-1 (S) + Cagrilintide, GLP-1 (S) + Cagrilintide Blend, Sema + Cagri Blend, Sema+Cagri
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
CagriSema · 4.28mg
1 vendors
B
Operational$56.99
$13.32/mg· $3.33/dose
In stockOn sale
| Vendor | Grade | Risk | Price | $/mg | Trend | $/dose at 0.25 mg | Stock | |
|---|---|---|---|---|---|---|---|---|
| MS Peptides US | B | Operational | $56.99 On sale | $13.32 | $3.33 | In stock | Buy with code → |
Sort:
Last crawl 2026-06-11Sort:
2026-06-11Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on CagriSema & related research
Related peptides
- Cagrilintide— Amylin analog for weight research
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Mazdutide— GLP-1/glucagon dual agonist
Compare head-to-head
Vendors selling this peptide